AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
Aurora Cannabis (TSX: ACB, NASDAQ: ACB) has urged shareholders to take no action regarding Curaleaf's (TSX: CURA, OTCQX: CURLF) unsolicited takeover bid of $4.00 per share, consisting of 0.3463 Curaleaf shares plus $0.75 in cash. Aurora's CEO, Miguel Martin, stated that Curaleaf's offer is designed to pressure shareholders into a short-term decision. Aurora has engaged with Curaleaf since June 2026 and plans to provide a comprehensive response to shareholders in due course.
How this was made
The 30-second read
Why it matters
The bid is below recent market prices, likely to trigger short‑term price weakness and heightened volatility for Aurora.
Market read
Primary M&A news for Aurora Cannabis with potential sector‑wide implications.
What to watch
Potential regulatory approvals and financing constraints for Curaleaf may delay or derail the transaction.
Background
Aurora Cannabis (NASDAQ: ACB) announced a hostile unsolicited takeover offer from Curaleaf Holdings, detailing the consideration mix and advising shareholders to wait for a board recommendation.
Ticker impact
Aurora Cannabis disclosed a hostile takeover bid by Curaleaf offering US$4.00 per share, prompting a shareholder advisory to take no action.
Downside pressure on ACB until the board issues a recommendation.
The bid is unsolicited and below recent trading levels, likely to depress the stock pending a response.
Market effects
The cannabis sector may see heightened M&A scrutiny and valuation pressure.
Canadian cannabis stocks could experience broader sell‑offs.
Limited to cannabis industry participants and investors with exposure to Aurora or Curaleaf.
Counterpoint
If Curaleaf secures the deal, synergies could unlock value, making Aurora a longer‑term upside play.
Key entities
- CompanyAurora Cannabis Inc.
Target of the takeover bid.
- CompanyCuraleaf Holdings, Inc.
Bidder proposing the acquisition.
